Abstract submitters may participate in the application process for the following awards:

DOP Awards

The winners of the Top 10 DOP awards are:

DOP05: Single-cell RNAseq temporal analysis of ulcerative colitis patients undergoing tofacitinib treatment reveals a shift in myeloid cells towards pro-inflammatory phenotypes in refractory patients - Elisa Melón-Ardanaz, Barcelona, Spain

DOP16: Anti-integrin ⍺vβ6 autoantibodies predate Ulcerative Colitis diagnosis by up to 10 years and are associated with adverse disease-related outcomes – Alexandra Livanos, New York, United States

DOP22: Antibiotic Use as a Risk Factor for Inflammatory Bowel Disease Across the Ages: A Population-Based Cohort Study – Adam Faye, New York, United States

DOP33: Single-cell analysis identifies pathological fibroblasts as a new therapeutic target to prevent intestinal fibrosis in Crohn’s Disease – Gianluca Matteoli, Leuven, Belgium

DOP53: Community types of the human gut virome are associated with endoscopic outcome in UC patients – Daan Jansen, Leuven, Belgium

DOP60: Environmental risk factors for Inflammatory bowel disease: A large prospective case-control study in India – Rupa Banerjee, Hyderabad, India

DOP68: Autophagy induction in the intestinal epithelium protects against inflammation-induced barrier loss in vivo – Kushal Saha, Hershey, United States

DOP80: Multi-omic sequencing reveals distinctive gene expression and DNA methylation alterations as potential predictors of primary sclerosing cholangitis development in treatment-naïve paediatric ulcerative colitis – Ololade Lawal, Dublin, Ireland

DOP85: Crohn's Disease Strictures Respond to Drug Treatment and Treat-to-Target Intense Combination Therapy is More Effective than Standard Anti-TNF Therapy. Two year results of the STRIDENT Randomised Controlled Trial – Julien Schulberg, Fitzroy, Australia

Best Investigator-Initiated Study (IIS) report submitted - IIS Abstract Award

The winners are:

OP02: Nicolas Pierre

OP37: Maria Chaparro

The Clinical Research Committee of ECCO (ClinCom) wants to stimulate the development of high-quality Investigator-Initiated Studies (IIS) in IBD and to improve the quality of IBD clinical studies in Europe through education. In 2023, awards will be given to the 2 best congress abstracts reporting on clinical studies set up by investigators (preferably multi-centre) submitted for the ECCO Congress. Note: Studies conducted by industry will not be eligible for this award.

Responsible Committee: Clinical Research Committee of ECCO (ClinCom)
Prize: Free registration for the ECCO Congress 2024
Number of awards: 2
Who can apply: ECCO Members reporting on clinical studies set up by investigators in their abstracts. Note: ECCO Membership fee 2023 must be paid up until the abstract submission deadline.
How to apply:

• In case you are not an ECCO Member yet please register for ECCO Membership 2023
• Log in to the ECCO'23 Abstract submission system
• At the beginning of the submission process please indicate if your abstract is qualified for the IIS Abstract Award
• Please pay careful attention to the general guidelines for abstract submission
• Upload your abstract for the ECCO Congress 2023
• Notification of the author in the beginning of December 2022
• Announcement at the ECCO'23 Congress

Y-ECCO Abstract Award

The winners are:

OP01: Sare Verstockt

OP18: Mads Damsgaard

OP29: Sun-Ho Lee

DOP05: Elisa Melón-Ardanaz

DOP57: Heidi Soegaard

The Young ECCO (Y-ECCO) encourages Y-ECCO Members to submit their abstract and share their research with the ECCO Community. Awards will be given to the 5 best-ranked abstracts along with a free congress registration for the following year.

Responsible Committee: Young-ECCO (Y-ECCO)
Prize: Free registration for the ECCO Congress 2024
Number of awards: 5
Who can apply: Y-ECCO Members (below 35 years of age or still in training). Note: ECCO Membership fee 2023 must be paid up until the abstract submission deadline.
How to apply:

• In case you are not an ECCO Member yet please register for ECCO Membership 2023
• Log in to the ECCO'23 Abstract submission system
• At the beginning of the submission process please indicate if your abstract is qualified for the Y-ECCO Abstract Award
• Please pay careful attention to the general guidelines for abstract submission
• Upload your abstract for the ECCO Congress 2023
• Notification of the author in the beginning of December 2022
• Announcement at the ECCO'23 Congress